IRIS Accounts Production v24.1.0.578 05678711 Board of Directors 1.1.23 31.12.23 31.12.23 true false true true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh056787112022-12-31056787112023-12-31056787112023-01-012023-12-31056787112021-12-31056787112022-01-012022-12-31056787112022-12-3105678711ns15:EnglandWales2023-01-012023-12-3105678711ns14:PoundSterling2023-01-012023-12-3105678711ns10:Director12023-01-012023-12-3105678711ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3105678711ns10:FRS1022023-01-012023-12-3105678711ns10:Audited2023-01-012023-12-3105678711ns10:LargeMedium-sizedCompaniesRegimeForDirectorsReport2023-01-012023-12-3105678711ns10:LargeMedium-sizedCompaniesRegimeForAccounts2023-01-012023-12-3105678711ns10:FullAccounts2023-01-012023-12-3105678711ns10:OrdinaryShareClass12023-01-012023-12-3105678711ns10:Director22023-01-012023-12-3105678711ns10:CompanySecretary12023-01-012023-12-3105678711ns10:RegisteredOffice2023-01-012023-12-3105678711ns5:CurrentFinancialInstruments2023-12-3105678711ns5:CurrentFinancialInstruments2022-12-3105678711ns5:Non-currentFinancialInstruments2023-12-3105678711ns5:Non-currentFinancialInstruments2022-12-3105678711ns5:ShareCapital2023-12-3105678711ns5:ShareCapital2022-12-3105678711ns5:RetainedEarningsAccumulatedLosses2023-12-3105678711ns5:RetainedEarningsAccumulatedLosses2022-12-3105678711ns5:ShareCapital2021-12-3105678711ns5:RetainedEarningsAccumulatedLosses2021-12-3105678711ns5:RetainedEarningsAccumulatedLosses2022-01-012022-12-3105678711ns5:RetainedEarningsAccumulatedLosses2023-01-012023-12-3105678711ns5:LeaseholdImprovements2023-01-012023-12-3105678711ns5:PlantMachinery2023-01-012023-12-3105678711ns5:FurnitureFittings2023-01-012023-12-3105678711ns5:ComputerEquipment2023-01-012023-12-3105678711ns5:ReportableOperatingSegment12023-01-012023-12-3105678711ns5:ReportableOperatingSegment12022-01-012022-12-3105678711ns5:TotalReportableOperatingSegmentsIncludingAnyUnallocatedAmount2023-01-012023-12-3105678711ns5:TotalReportableOperatingSegmentsIncludingAnyUnallocatedAmount2022-01-012022-12-3105678711ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2023-01-012023-12-3105678711ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2022-01-012022-12-3105678711ns5:OwnedAssets2023-01-012023-12-3105678711ns5:OwnedAssets2022-01-012022-12-310567871152023-01-012023-12-310567871152022-01-012022-12-3105678711ns5:LeaseholdImprovements2022-12-3105678711ns5:PlantMachinery2022-12-3105678711ns5:FurnitureFittings2022-12-3105678711ns5:ComputerEquipment2022-12-3105678711ns5:LeaseholdImprovements2023-12-3105678711ns5:PlantMachinery2023-12-3105678711ns5:FurnitureFittings2023-12-3105678711ns5:ComputerEquipment2023-12-3105678711ns5:LeaseholdImprovements2022-12-3105678711ns5:PlantMachinery2022-12-3105678711ns5:FurnitureFittings2022-12-3105678711ns5:ComputerEquipment2022-12-3105678711ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3105678711ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3105678711ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2023-12-3105678711ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2022-12-3105678711ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-12-3105678711ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2022-12-3105678711ns5:WithinOneYear2023-12-3105678711ns5:WithinOneYear2022-12-3105678711ns5:BetweenOneFiveYears2023-12-3105678711ns5:BetweenOneFiveYears2022-12-3105678711ns5:MoreThanFiveYears2023-12-3105678711ns5:MoreThanFiveYears2022-12-3105678711ns5:AllPeriods2023-12-3105678711ns5:AllPeriods2022-12-3105678711ns5:Secured2023-12-3105678711ns5:Secured2022-12-3105678711ns5:DeferredTaxation2022-12-3105678711ns5:DeferredTaxation2023-01-012023-12-3105678711ns5:DeferredTaxation2023-12-3105678711ns10:OrdinaryShareClass12023-12-31
REGISTERED NUMBER: 05678711 (England and Wales)












STRATEGIC REPORT, REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2023

FOR

THE PLACEMENT GROUP HEALTHCARE LIMITED

THE PLACEMENT GROUP HEALTHCARE LIMITED (REGISTERED NUMBER: 05678711)






CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 December 2023




Page

Company Information 1

Strategic Report 2

Report of the Directors 5

Report of the Independent Auditors 7

Income Statement 11

Statement of Comprehensive Income 12

Balance Sheet 13

Statement of Changes in Equity 14

Notes to the Financial Statements 15


THE PLACEMENT GROUP HEALTHCARE LIMITED

COMPANY INFORMATION
for the year ended 31 December 2023







DIRECTORS: Mr E C Simpson
Mr S Porter





SECRETARY: Mr S Porter





REGISTERED OFFICE: 110 Brooker Road
Waltham Abbey
Essex
EN9 1JH





REGISTERED NUMBER: 05678711 (England and Wales)





AUDITORS: Raffingers LLP, Statutory Auditor
19-20 Bourne Court
Southend Road
Woodford Green
Essex
IG8 8HD

THE PLACEMENT GROUP HEALTHCARE LIMITED (REGISTERED NUMBER: 05678711)

STRATEGIC REPORT
for the year ended 31 December 2023

The directors present their strategic report for the year ended 31 December 2023.

REVIEW OF BUSINESS
The result for the year is shown on page 11.

Gross profit has increased by £154,589 from £3,915,485 to £4,070,074 (4%). Sales figure for the year has increased to £19.2m compared to £18.3m in the previous year, as the company recovered from the adverse effects Covid 19.

As shown in the profit and loss account, the operating profit for continuing operations for the year was £553,839 (2022 - £376,929).

The balance sheet on page 13 shows net assets of £2,568,889 (2022 - £2,207,585) at the end of the year, with a positive cash position of £87,501 (2022 - £138,613).

In 2023, demand for our services remained robust, particularly within our Nursing and Healthcare Divisions. Our largest Nursing Team successfully secured inclusion in a new Framework, enhancing our trading platform in this region.

Our Clinical Governance Board played a pivotal role in upholding our quality assurance policy, resulting in improved client retention. The successful attainment of our ISO 9001 accreditation further underscores our commitment to delivering high-quality services. All divisions consistently maintained high compliance standards with National Staffing Frameworks.

We continued to leverage technology to enhance our operations. Further development of our Customer Relationship Management (CRM) system has streamlined operations, improved communication, and facilitated better collaboration across the company.

Investing in people and team development remains a priority. We believe a motivated workforce is crucial for achieving financial targets and long-term success. We will continue initiatives that foster professional growth, collaboration, and recognise outstanding performance.


THE PLACEMENT GROUP HEALTHCARE LIMITED (REGISTERED NUMBER: 05678711)

STRATEGIC REPORT
for the year ended 31 December 2023

PRINCIPAL RISKS AND UNCERTAINTIES
The company's operations expose it to a variety of financial risks that include the effects of changes in credit risk, liquidity risk and interest rate risk.

The company has in place a risk management programme that seeks to limit the adverse effects on the financial performance of the company by monitoring levels of debt finance and the related finance costs. The company does not use derivative financial instruments to manage interest rate costs and as such, no hedge accounting is applied.

Given the size of the company, the directors have not delegated the responsibility of monitoring financial risk management to a sub-committee of the board. The policies set by the board of directors are implemented by the finance department.

Price risk
The company is exposed to price risk due to normal inflationary increases in the purchase price of the goods and services purchased in the UK. The company has no exposure to equity securities price risk as it holds no listed or other equity investments.

Liquidity risk
The company actively maintains short-term debt finance that is designed to ensure that the company has sufficient available funds for operations and planned expansions.

Interest rate risk
The company has both interest bearing assets and interest bearing liabilities. Interest bearing assets include only cash balances which earn interest at fixed rate. The company has a policy of maintaining debt at a fixed rate to ensure certainty of future interest cash flows. The directors will revisit the appropriateness of this policy if the operations of the company change in size or nature.

CORPORATE SOCIAL RESPONSIBILITY
- Health and safety policy and performance is monitored and updated on an annual basis.

- The company delivers specialist recruitment services across the entire arena of healthcare and ensures that competent and qualified people are selected.

- Other examples of polices implemented by the company in order to comply with the spirit of the law and maintain the ethical standards are: equal opportunities, harassment, training and career development.


THE PLACEMENT GROUP HEALTHCARE LIMITED (REGISTERED NUMBER: 05678711)

STRATEGIC REPORT
for the year ended 31 December 2023

KEY PERFORMANCE INDICATORS
- Customer satisfaction and retention - has improved over the years especially considering the relationships developed with our existing client base which is reflected in the increase in new contracts with existing customers.

- Employee Satisfaction - maintaining of staff morale has been a key factor in the conpany's growth. The company has introduced measures to evaluate and improve employee satisfaction.

- Gross profit margin - margin has been improving in the last few years due to constant monitoring and introduction of efficiencies. However, it has decreased slightly in the current year due to general increase in skilled labour costs.

2023 2022 Measure
Gross profit margin 21.2% 21.4% Gross profit/turnover

- Debtor days - a slight increase in debtor days. The debtor days have been improving due to measures put in to help the group to maintain a healthy cash position and reduce creditors days as shown below.

2023 2022 Measure
Debtor days 43 days 39 days Trade debtors/turnover

- Creditor days - the creditor days are generally low as bulk of the cost of sales consists of wages paid to locum staff which are settled on a weekly basis.

2023 2022 Measure
Creditor days 15 days 17 days Trade creditors/cost of sales

ON BEHALF OF THE BOARD:





Mr E C Simpson - Director


27 June 2024

THE PLACEMENT GROUP HEALTHCARE LIMITED (REGISTERED NUMBER: 05678711)

REPORT OF THE DIRECTORS
for the year ended 31 December 2023

The directors present their report with the financial statements of the company for the year ended 31 December 2023.

PRINCIPAL ACTIVITY
The principal activity of the company in the year under review was that of a medical placement agency.

DIVIDENDS
No dividends will be distributed for the year ended 31 December 2023.

FUTURE DEVELOPMENTS
Please refer to the Strategic Report.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 January 2023 to the date of this report.

Mr E C Simpson
Mr S Porter

GOING CONCERN
The directors have assessed whether the use of the going concern assumption is appropriate in preparing these accounts. They have made this assessment in respect to a period of one year from the date of approval of these accounts.

The directors have carefully considered the impact of the macroeconomic uncertainties, the conflict in Ukraine and potential supplier chain issues caused by Brexit on the company's financial position, liquidity and future performance. As set out in the strategic report, the company has continued to trade strongly throughout this year and the directors believe that it is experiencing good levels of sales growth and profitability. Therefore, the directors believe that the company is well placed to manage its business risks successfully.

Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. They have concluded that there are no material uncertainties related to events or conditions that may cast significant doubt on the ability of the company to continue as a going concern.

EMPLOYEES
The company operates an equal opportunities policy. The aim of this policy is to ensure that there should be equal opportunity for all and this applies external recruitment, internal appointments, terms of employment, conditions of service and opportunity for training and promotion regardless of gender, ethnic origin or disability.

Disabled persons are given full and fair consideration for all types of vacancy in as much as the opportunities available are constrained by the practical limitations of the disability. Should, for whatever reason, an employee of the company becomes disabled whilst in the employment, every step, where appropriate will be taken to assist with rehabilitation and suitable re-training.

The company maintains its own health, safety and environmental policies covering all aspect of its operations. Regular meetings and inspections take place to ensure all legal requirements are adhered to and that the company is responsive to the needs of the employees and the environment.


THE PLACEMENT GROUP HEALTHCARE LIMITED (REGISTERED NUMBER: 05678711)

REPORT OF THE DIRECTORS
for the year ended 31 December 2023

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

ON BEHALF OF THE BOARD:





Mr E C Simpson - Director


27 June 2024

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
THE PLACEMENT GROUP HEALTHCARE LIMITED

Opinion
We have audited the financial statements of The Placement Group Healthcare Limited (the 'company') for the year ended 31 December 2023 which comprise the Income Statement, Statement of Comprehensive Income, Balance Sheet, Statement of Changes in Equity and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 December 2023 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
THE PLACEMENT GROUP HEALTHCARE LIMITED


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page six, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
THE PLACEMENT GROUP HEALTHCARE LIMITED


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:
- the engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations;
- we identified the laws and regulations applicable to the company through discussions with directors and other management, and from our commercial knowledge and experience of the company sector;
- we focused on specific laws and regulations which we considered may have a direct material effect on the financial statements or the operations of the company, including the Companies Act 2006, taxation legislation and data protection, employment, and health and safety legislation and NHS Framework requirements;
- we assessed the extent of compliance with the laws and regulations identified above through making enquiries of management and inspecting legal correspondence where necessary.

We assessed the susceptibility of the company's financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:
- making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud; and
- considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations.

To address the risk of fraud through management bias and override of controls, we:
- performed analytical procedures to identify any unusual or unexpected transactions;
- tested the appropriateness of journal entries;
- assessed whether judgements and assumptions made in determining the accounting estimates were indicative of potential bias; and
- investigated the rationale behind significant or unusual transactions.

To address the risk that revenue could be misstated due to fraud, we:
- we obtained an understanding of the company's revenue recognition policies and compared these to the accounting standard;
- performed a walkthrough to confirm our understanding of the processes and controls through which the business initiates, records, processes and reports revenue transactions;
- tested a sample of revenue transactions to supporting evidence; and
- tested, on a sample basis, revenue related balances in the balance sheet.

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:
- agreeing financial statement disclosures to underlying supporting documentation;
- reading the minutes of meetings of those charged with governance;
- enquiring of management as to actual and potential litigation and claims; and
- reviewing correspondence with HMRC, relevant regulators, and the company's legal advisors.

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.


REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
THE PLACEMENT GROUP HEALTHCARE LIMITED

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Lee Elliot Manning (Senior Statutory Auditor)
for and on behalf of Raffingers LLP, Statutory Auditor
19-20 Bourne Court
Southend Road
Woodford Green
Essex
IG8 8HD

27 June 2024

THE PLACEMENT GROUP HEALTHCARE LIMITED (REGISTERED NUMBER: 05678711)

INCOME STATEMENT
for the year ended 31 December 2023

2023 2022
Notes £    £   

TURNOVER 3 19,213,283 18,314,855

Cost of sales (15,143,209 ) (14,399,370 )
GROSS PROFIT 4,070,074 3,915,485

Administrative expenses (3,591,656 ) (3,651,904 )
478,418 263,581

Other operating income 75,421 113,348
OPERATING PROFIT 5 553,839 376,929


Interest payable and similar expenses 6 (77,544 ) (58,524 )
PROFIT BEFORE TAXATION 476,295 318,405

Tax on profit 7 (114,991 ) 19,561
PROFIT FOR THE FINANCIAL YEAR 361,304 337,966

THE PLACEMENT GROUP HEALTHCARE LIMITED (REGISTERED NUMBER: 05678711)

STATEMENT OF COMPREHENSIVE
INCOME
for the year ended 31 December 2023

2023 2022
Notes £    £   

PROFIT FOR THE YEAR 361,304 337,966


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

361,304

337,966

THE PLACEMENT GROUP HEALTHCARE LIMITED (REGISTERED NUMBER: 05678711)

BALANCE SHEET
31 December 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 8 98,439 280,931

CURRENT ASSETS
Debtors 9 5,034,014 5,202,867
Cash at bank and in hand 87,501 138,613
5,121,515 5,341,480
CREDITORS
Amounts falling due within one year 10 2,285,130 2,669,086
NET CURRENT ASSETS 2,836,385 2,672,394
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,934,824

2,953,325

CREDITORS
Amounts falling due after more than one year 11 (362,963 ) (740,741 )

PROVISIONS FOR LIABILITIES 15 (2,972 ) (4,999 )
NET ASSETS 2,568,889 2,207,585

CAPITAL AND RESERVES
Called up share capital 16 10,000 10,000
Retained earnings 2,558,889 2,197,585
SHAREHOLDERS' FUNDS 2,568,889 2,207,585

The financial statements were approved by the Board of Directors and authorised for issue on 27 June 2024 and were signed on its behalf by:





Mr E C Simpson - Director


THE PLACEMENT GROUP HEALTHCARE LIMITED (REGISTERED NUMBER: 05678711)

STATEMENT OF CHANGES IN EQUITY
for the year ended 31 December 2023

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 January 2022 10,000 1,859,619 1,869,619

Changes in equity
Total comprehensive income - 337,966 337,966
Balance at 31 December 2022 10,000 2,197,585 2,207,585

Changes in equity
Total comprehensive income - 361,304 361,304
Balance at 31 December 2023 10,000 2,558,889 2,568,889

THE PLACEMENT GROUP HEALTHCARE LIMITED (REGISTERED NUMBER: 05678711)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 December 2023

1. STATUTORY INFORMATION

The Placement Group Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Assessment of going concern
The directors have assessed whether the use of the going concern assumption is appropriate in preparing these accounts. The directors have made this assessment in respect to a period of one year from the date of approval of these accounts.

The directors have concluded that there are no material uncertainties related to events or conditions that may cast significant doubt on the ability of the company to continue as a going concern. The directors are of the opinion that the company will have sufficient resources to meet its liabilities as they fall due.

In arriving at the conclusion, the directors have considered the potential implications of Brexit on the company. The directors have discussed the effects of Brexit on the availability of locum staff and have concluded that there will not be any detrimental effects in the near future.

Critical accounting judgements
The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the company's accounting policies.

The items in the accounts where these judgements and estimates have been made, include:
- estimating the useful economic life of tangible fixed assets for the purpose of calculating the depreciation charge;
- assessing the recoverability of outstanding debtors;
- determining the percentage of expenses recharged between group companies;
- determining the fees charged between group companies with regards to usage of brands held.

Financial Reporting Standard 102 - reduced disclosure exemptions
The company has taken advantage of the following disclosure exemption in preparing these financial statements, as permitted by FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":

the requirements of Section 7 Statement of Cash Flows.

THE PLACEMENT GROUP HEALTHCARE LIMITED (REGISTERED NUMBER: 05678711)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2023

2. ACCOUNTING POLICIES - continued

Turnover
Turnover represents net invoiced sales of services, excluding value added tax. Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services.

Contract revenue is recognised based on the number of contractor hours worked multiplied by the agreed hourly rate. Revenue not invoiced by the end of the period is accrued within debtors.

Grant income
Government grants, including non-monetary grants shall not be recognised until there is reasonable assurance
that:
(a) the entity will comply with the conditions attached to them; and
(b) the grants will be received.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - Straight line over the life of the lease
Plant and machinery - 25% on cost
Boat - Not provided
Computer equipment - 25% on cost

A boat was acquired during the year. Depreciation was not provided as the boat was disposed of for the same value in June 2023.

Financial instruments
Basic financial assets, including trade and other receivables and cash and bank balances are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Such assets are subsequently carried at amortised cost using the effective interest method.

Basic financial liabilities, including trade and other payables, bank loans, that are classified as debt, initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


THE PLACEMENT GROUP HEALTHCARE LIMITED (REGISTERED NUMBER: 05678711)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2023

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method unless the effect of discounting would be immaterial, in which case they are stated at cost.

THE PLACEMENT GROUP HEALTHCARE LIMITED (REGISTERED NUMBER: 05678711)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2023

2. ACCOUNTING POLICIES - continued

Trade and other debtors
Trade and other debtors that are receivable within one year and do not constitute a financing transaction are recorded at the undiscounted amount expected to be received, net of impairment. Those that are receivable after more than one year or that constitute a financing transaction are recorded initially at fair value less transaction costs and subsequently at amortised cost, net of impairment.

Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and in hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less and bank overdrafts. In the statement of financial position, bank overdrafts are shown within borrowings or current liabilities.

Related parties
For the purposes of these financial statements, a party is considered to be related to the company if:
- the party has the ability, directly or indirectly, through one or more intermediaries, to control the Company or exercise significant influence over the company in making financial and operating policy decisions, or has joint control over the company; or
- the company and the party are subject to common control; or
- the party is an associate of the company or a joint venture in which the company is a venturer; or
- the party is a member of key management personnel of the company or the company's parent, or a close family member of such an individual, or is an entity under the control, joint control or significant influence of such individuals; or
- the party is a close family member of a party referred to in (i) or is an entity under the control, joint control or significant influence of such individuals; or
- the party is a post-employment benefit plan which is for the benefit of employees of the company or of any entity that is a related party of the company; or
- the party, or any member of a group of which it is part, provides key management personnel services to the company or its parent.

3. TURNOVER

The turnover and profit before taxation are attributable to the one principal activity of the company.

An analysis of turnover by class of business is given below:

2023 2022
£    £   
Locum fees 19,213,283 18,314,855
19,213,283 18,314,855

4. EMPLOYEES AND DIRECTORS
2023 2022
£    £   
Wages and salaries 2,250,272 2,134,801
Social security costs 244,141 240,144
Other pension costs 80,013 70,394
2,574,426 2,445,339

THE PLACEMENT GROUP HEALTHCARE LIMITED (REGISTERED NUMBER: 05678711)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2023

4. EMPLOYEES AND DIRECTORS - continued

The average number of employees during the year was as follows:
2023 2022

Administration 30 23
Sales 67 70
97 93

2023 2022
£    £   
Directors' remuneration 140,281 172,447

5. OPERATING PROFIT

The operating profit is stated after charging:

2023 2022
£    £   
Hire of plant and machinery 420 345
Depreciation - owned assets 43,226 49,464
Auditors' remuneration 21,530 42,113

6. INTEREST PAYABLE AND SIMILAR EXPENSES
2023 2022
£    £   
Bank loan interest 71,433 42,952
Other finance interest 6,111 15,572
77,544 58,524

7. TAXATION

Analysis of the tax charge/(credit)
The tax charge/(credit) on the profit for the year was as follows:
2023 2022
£    £   
Current tax:
UK corporation tax 117,018 (16,537 )

Deferred tax:
Origination and reversal of timing differences (2,027 ) (3,024 )
Tax on profit 114,991 (19,561 )

UK corporation tax has been charged at 23.52% (2022 - 19%).

THE PLACEMENT GROUP HEALTHCARE LIMITED (REGISTERED NUMBER: 05678711)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2023

7. TAXATION - continued

Reconciliation of total tax charge/(credit) included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

2023 2022
£    £   
Profit before tax 476,295 318,405
Profit multiplied by the standard rate of corporation tax in the UK of
23.520% (2022 - 19%)

112,025

60,497

Effects of:
Expenses not deductible for tax purposes 15 88
Depreciation in excess of capital allowances 4,978 3,779
Research and development - (80,901 )
Deferred tax (2,027 ) (3,024 )

Total tax charge/(credit) 114,991 (19,561 )

8. TANGIBLE FIXED ASSETS
Improvements
to Plant and Computer
property machinery Boat equipment Totals
£    £    £    £    £   
COST
At 1 January 2023 234,040 9,986 155,000 82,234 481,260
Additions - 9,131 - 6,603 15,734
Disposals - - (155,000 ) (13,131 ) (168,131 )
At 31 December 2023 234,040 19,117 - 75,706 328,863
DEPRECIATION
At 1 January 2023 134,745 4,950 - 60,634 200,329
Charge for year 23,364 3,716 - 16,146 43,226
Eliminated on disposal - - - (13,131 ) (13,131 )
At 31 December 2023 158,109 8,666 - 63,649 230,424
NET BOOK VALUE
At 31 December 2023 75,931 10,451 - 12,057 98,439
At 31 December 2022 99,295 5,036 155,000 21,600 280,931

THE PLACEMENT GROUP HEALTHCARE LIMITED (REGISTERED NUMBER: 05678711)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2023

9. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 2,253,270 1,948,989
Amounts owed by group undertakings 2,044,801 2,765,676
Other debtors 501,607 355,214
Tax - 80,900
Accrued income 234,336 52,088
5,034,014 5,202,867

10. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Bank loans and overdrafts (see note 12) 377,777 377,777
Trade creditors 630,764 656,428
Amounts owed to group undertakings 271,175 186,002
Tax 117,018 64,363
Social security and other taxes 270,385 337,299
Other creditors 398,124 781,046
Accrued expenses 219,887 266,171
2,285,130 2,669,086

11. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2023 2022
£    £   
Bank loans (see note 12) 362,963 740,741

12. LOANS

An analysis of the maturity of loans is given below:

2023 2022
£    £   
Amounts falling due within one year or on demand:
Bank loans 377,777 377,777

Amounts falling due between one and two years:
Bank loans 362,963 377,778

Amounts falling due between two and five years:
Bank loans - 362,963

THE PLACEMENT GROUP HEALTHCARE LIMITED (REGISTERED NUMBER: 05678711)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2023

13. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2023 2022
£    £   
Within one year 180,000 180,000
Between one and five years 720,000 720,000
In more than five years 787,068 967,068
1,687,068 1,867,068

14. SECURED DEBTS

The following secured debts are included within creditors:

2023 2022
£    £   
Bank loans 740,740 1,118,518
Invoice financing - Clydesdale 153,587 698,984
894,327 1,817,502

Bank loans were received under Bounce Back Loan Scheme. The facility is supported by the Enterprise Finance Guarantee programme, managed by the British Business Bank on behalf of, and with the financial backing of, the Secretary of State for Business, Energy and Industrial Strategy.

The other creditors at the balance sheet date contain a liability of £153,587 (2022 - £698,984) in respect of proceeds received from Clydesdale Bank plc.

Funding advance from Clydesdale Bank plc is secured by a charge over the debtors book and a debenture creating a fixed and floating charge over the assets of the company.

15. PROVISIONS FOR LIABILITIES
2023 2022
£    £   
Deferred tax 2,972 4,999

Deferred
tax
£   
Balance at 1 January 2023 4,999
Utilised during year (2,027 )
Balance at 31 December 2023 2,972

The amount for provisions for liabilities consist of deferred tax liabilities that arose due to timing differences on accelerated capital allowances.

THE PLACEMENT GROUP HEALTHCARE LIMITED (REGISTERED NUMBER: 05678711)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2023

16. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
10,000 Ordinary £1 10,000 10,000

17. PENSION COMMITMENTS

The company operates a defined contribution scheme. The assets of the scheme are held separately from those of the company, being invested with an insurance company. During the year contributions payable by the company to the fund amounted to £80,013 (2022 - £70,394). There were no prepaid or accrued contributions at 31 December 2023 or 31 December 2022.

18. PARENT COMPANY

The Placement Group Plc, a company registered in England and Wales, is the immediate and ultimate parent company. The smallest and largest group in which the results of the company will be consolidated is The Placement Group Plc, whose accounts can be obtained from the registered office at 110 Brooker Road, Waltham Abbey, Essex EN9 1JH.

19. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

During the year, the company paid rent of £180,000 (2022 - £180,000) to Pixel Business Centres Ltd, a company solely owned by the director, Mr E C Simpson. The loans to Pixel Business Centres Ltd, repayable on demand, were at an interest rate of 3% per annum. At the balance sheet date, Pixel Business Centres Ltd owed the company £364,591 (2022 - £331,846).

At the balance sheet date, Medico Staffing Limited, a company solely owned by the director, Mr E C Simpson owed the company £106,440 (2022 - £1,440).